REGULATED PRESS RELEASE
News
-
-
-
-
-
-
REGULATED PRESS RELEASE
Successful capital increase for NFL Biosciences with over €3 million raised
NFL Biosciences successfully raises over €3 million in capital increase, securing funds for upcoming Phase 3 clinical trial of NFL-101 and advancing development of NFL-301. New shares to be listed on Euronext Growth Paris on April 16, 2024 -
-
REGULATED PRESS RELEASE
NFL Biosciences launches a fundraising round for 3 million euros through a capital increase
NFL Biosciences launches a fundraising round for 3 million euros through a capital increase, aiming to support Phase 3 clinical trial for NFL-101 and development of NFL-301 drug candidates -
-
REGULATED PRESS RELEASE
NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
-
LaMar’s Donuts Celebrates National Donut Day 2024
-
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
-
abrdn Income Credit Strategies Fund Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust High Income Long/Short Fund
-
Electric Royalties Announces Interest Conversion Under Convertible Credit Facility
-
Pfister Faucets' American Plumber Stories Docuseries Wins Three Telly Awards
-
EQS-Adhoc: Vectron Systems AG: Vectron enters into Business Combination Agreement, resolves 10% capital increase without subscription rights of the shareholders and supports voluntary public acqusition offer
-
CPI PROPERTY GROUP publishes financial results for the first quarter of 2024
-
Leclanché SA: Publishes its Annual Report 2023 and Non-financial ESG Report
-
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
ACCOR - Description of own share buyback programme
-
ACCOR - Press release following the 2024 general meeting
-
Capital increase through exercise of subscription rights
-
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
-
Thales has completed the sale of its Ground Transportation Systems business